KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Non Operating Income (2016 - 2025)

Amgen (AMGN) has 17 years of Non Operating Income data on record, last reported at -$553.0 million in Q4 2025.

  • For Q4 2025, Non Operating Income rose 29.28% year-over-year to -$553.0 million; the TTM value through Dec 2025 reached $2.7 billion, up 423.91%, while the annual FY2025 figure was $2.7 billion, 423.91% up from the prior year.
  • Non Operating Income reached -$553.0 million in Q4 2025 per AMGN's latest filing, down from $2.1 billion in the prior quarter.
  • Across five years, Non Operating Income topped out at $2.1 billion in Q3 2025 and bottomed at -$782.0 million in Q4 2024.
  • Average Non Operating Income over 5 years is $271.8 million, with a median of $12.0 million recorded in 2021.
  • Peak YoY movement for Non Operating Income: tumbled 4176.92% in 2022, then surged 745.96% in 2025.
  • A 5-year view of Non Operating Income shows it stood at $162.0 million in 2021, then crashed by 141.36% to -$67.0 million in 2022, then surged by 700.0% to $402.0 million in 2023, then plummeted by 294.53% to -$782.0 million in 2024, then rose by 29.28% to -$553.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were -$553.0 million in Q4 2025, $2.1 billion in Q3 2025, and -$394.0 million in Q2 2025.